Member Info for Wigster77

I presume you'll be attending the AGM this year to voice any of your concerns to the board, Professional?

What sort of climax were you expecting?

I wouldn't get your hopes up...

Thanks Brand

Cheers Tommy.

What time's our presentation and can you watch it on line? (Sorry, at work and unable to check)

@Manifesto. The below is from a poster called Spacman, a "LTH" who mysteriously appeared out of the blue last month and bored everyone into submission about SPACS, before mercifully disappearing. I've not checked his/her figures, but it does seem feasible that we could have funds to last in a "tick-over" capacity for longer than previously indicated. Not that we particularly want tickover for too much longer of course...

----------------------

The runway is at least 3 years.

The company had £18m in cash as at 30/6/22.

"In the last full-year's accounts (2021), payroll costs inc. directors was £2,860k. Assuming a couple of incremental hires on the headcount and a 12% salary increase as per the previous year, then that figure should still sit below £3.5m. Assuming de minimus necessary overheads such as premises, that would suggest this company can sit in a holding pattern for around 3.5 years from now. Not many companies have that luxury!"

Just puzzling why they would chose now to recruit for a £250K Associate Director of Medical Affairs if there was nothing positive going on in the background.

I'm quietly confident of an RNS tomorrow to announce a £10bn takeover of Synairgen. I hope that I don't have to cancel my appointment at the local Ferrari dealer for the second February on the trot...

Yes, J&J/Janssen are clearly on the same page as us with a lot of things otherwise they wouldn't have bothered with something like the UNIVERSAL trial.

It's possible this article was paid for in October/November time when they were planning the panel discussion.

Was going to comment that there's been some useful debate and contributions this week. Long may it continue.

ATB & GLA.

Seems positive Mid year (if it’s us) but nearly out of cash?
Thoughts?
----
Won't be an issue. We'll still have plenty of 50p's for the meter and to buy a few more tea-bags for Maud.

gunto: S"econd agent still unknown and latest I read, mid-year. Could be an indicator that whatever the second agent is, it is more complex than Shionogi’s protocol."

I take it you're referring to this post on the ADVFN Funny-Farm, by the learned and renowned Shoots101:

"Will now share for all even though Gunts will do his best to deride it in his fabulous judgement whilst he hypes the fake stuff Hi Rob,All well here in the States.STRIVE has opened sites and is working through international regulatory filings. We have not yet had the first patient enroll, which is why the public announcement has not yet happened. Basic information on the trial can be found here on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT05605093?term=STRIVE&cond=COVID-19&draw=2&rank=1.Next drug likely to announce/start midyear.Thanks,StaceyStacey J. Adam, PhD (she/her)Associate Vice PresidentResearch Partnerships"

----
No reason to doubt such an admired poster, but bear in mind that we knew about Shionogi being on STRIVE way back in October and they've only just publically announced it today, so the same delay from "announcement" on the NIH website for all to see, to "public announcement" could apply to the second agent. i.e. it could still pop up on the NIH website at any time.

ATB, GLA & DYOR

Great, so after the numerous fruitless "false starts" of the many many other conferences we attended during 2022, this is THE ONE!! The one which will unlock the doors to commercialisation. Fantastic news.

(Apologies for the MrCosts levels of sarcasm....just the frustrations and impatience coming through).

ATB & GLA

What CROI is not is a membership society event, commercially driven, or a government funded event. It is not a pay for play event."

Or more succinctly: "pointless for Synairgen to attend"

Cheers Fruits. If he is indeed presenting it'll be interesting to compare with previous attempts by Dr Monk.

Thanks also Brand for the find...a timely crumb of action in amongst the painful patience testing radio silence.

GLA (except Andybe4).

Just catching up, so sorry if already answered...do we know who is doing the presenting at this conference? And Prasanna Jagannathan is a new name on me...is he/she a Synairgen bod?

5 weeks of winter left. After that I will conclude that we're now in Spring.

In all seriousness, yes, there is zero chance of us dosing patients this winter (unless giving sedatives to long-suffering and increasingly impatient investors counts).

I agree with TP that it's high time we had a concrete update of future plans from the company. For all we know they could be cracking open the champagne celebrating a $20Bn takeover...or whiling away their days playing solitaire and I-spy whilst waiting for the magical trial telephone to ring.

Happy to report that Maud is safe and well. Down to her last few boxes of specially discounted tea-bags though, and anxiously awaiting a positive RNS from the company...hopefully resulting in funds to replenish her supply. Wishes all LTHs well.